Effect of topical injection of dextrose and corticosteroids in treatment of sacroiliac joint inflammatio
Phase 3
- Conditions
- Inflammation of the sacroiliac joint.Sacroiliitis, not elsewhere classified
- Registration Number
- IRCT20170910036107N2
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Diagnosis of sacroiliac (Sl) joint pain
Failure to respond to medication for one month
Having a score of at least 4 in the Visual Analog Scale (VAS) criteria
Exclusion Criteria
Malignancy
Fractures
Inflammatory arthritis
Infections
Fibromyalgia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of symptoms. Timepoint: Before injection, 2 weeks and 8 weeks after injection. Method of measurement: Visual Analog Scale (VAS).;The severity of symptoms and functional limitations in chronic low back pain. Timepoint: Before injection, 2 weeks and 8 weeks after injection. Method of measurement: Dallas questionnaire.
- Secondary Outcome Measures
Name Time Method